231 Users Online
A Detailed Analysis of the Neurointerventional Device Market Based on an Increasing Demand for Minimally Invasive Procedures, and Rapid Technological Advancements
The global neurointerventional device market is forecast to expand at a CAGR of 4.7% and thereby increase from a value of US$26 Bn in 2023, to US$ 35.8 Bn by the end of 2030.
Neurointerventional Device Market Size (2023E)
Projected Market Value (2030F)
Global Market Growth Rate (CAGR 2023 to 2030)
Historical Market Growth Rate (CAGR 2018 to 2022)
Neurointerventional devices are specialized medical instruments and apparatus that are employed during minimally invasive procedures aimed at diagnosing and treating a wide range of disorders that impact the central nervous system. Catheters, stents, embolic agents, and imaging technologies are frequently employed during these procedures to treat and navigate neurovascular disorders such as vascular malformations, aneurysms, and strokes. By reducing recovery times, mitigating risks associated with invasive procedures, and offering less invasive alternatives to conventional surgical methods, neurointerventional devices are vital in enhancing patient outcomes.
The global market for neurointerventional devices is influenced by numerous factors. Progress in imaging modalities and device design is a significant factor in the improved accuracy and effectiveness of neurointerventional procedures. A combination of a growing elderly population and an increase in the incidence of neurological disorders generates a greater demand for neurointerventional treatments. Moreover, the increasing recognition among healthcare practitioners and patients regarding the advantages of minimally invasive procedures serves as an additional catalyst for market expansion. Furthermore, ongoing research and development endeavors to introduce novel devices and therapies contribute to the worldwide growth of the neurointerventional device market.
Incorporating and Continuously Advancing State-of-the-Art Technologies in Neurointerventional Procedures
An important factor propelling the global neurointerventional device market is the integration and ongoing development of state-of-the-art technologies during neurointerventional procedures. The introduction of sophisticated imaging techniques, including computed tomography (CT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA), has significantly transformed the level of accuracy and precision that neuro interventionalists can employ to diagnose and manage a wide range of conditions that impact the central nervous system.
Real-time, high-resolution imaging is made possible by these technologies, enabling precise manoeuvring through complex neural structures throughout procedures. The amalgamation of computer-assisted navigation systems and three-dimensional imaging augments the capacity of neurointerventionalists to visually perceive and traverse intricate anatomical formations, thereby leading to enhanced patient outcomes.
In addition, the integration of novel device configurations and substances has made a substantial impact on the effectiveness and security of neuro-interventional procedures. As an illustration, the reduction in friction experienced while traversing fragile blood vessels by catheters and stents due to the development of biocompatible and flexible materials has substantially diminished the likelihood of vessel injury.
Furthermore, the advent of detachable and bioresorbable devices has expanded the repertoire of neurointerventionalists in customizing therapies to suit the unique requirements of each patient. Enhanced biocompatibility and targeted delivery mechanisms of flow diverters and embolic agents have contributed to the broader applicability of neuro interventional techniques. In addition to enabling more precise diagnoses and targeted treatments, these technological developments also reduce post-procedural complications and shorten recovery periods, thereby bolstering the market for neurointerventional devices as a whole.
High Costs Associated with Advanced Medical Technologies
One notable factor impeding the growth of the worldwide neurointerventional device market is the exorbitant expense linked to these cutting-edge medical technologies. Considerable investments are allocated to research and development for the implementation of advanced imaging technologies and devices in neuro-interventional procedures, including their design, production, and integration.
In addition, the rigorous regulatory requirements for the approval of these devices and their intricate nature contribute to the exorbitant expenses associated with their production. Consequently, the utilization of specialized devices and the excessive expenses associated with neuro interventional procedures can pose a significant financial burden on healthcare providers and patients alike. The exorbitant expense presents obstacles to extensive implementation, especially in areas where financial means and healthcare infrastructure are constrained.
Complexity and Diversity in Neurological Disorders
The variability and complexity of neurological disorders, which can impede the development of standardized treatment approaches and devices, constitute a formidable force in the global neurointerventional device market. Neurological disorders manifest in a wide variety of ways, which complicates the development of universally applicable solutions. Customized interventions are necessary due to the complex construction of the central nervous system, which is further complicated by the diversity of patient cases. To tackle this challenge, continuous research, and development endeavours are necessary to produce neuro-interventional devices that are adaptable and versatile enough to accommodate the various requirements of patients with neurological disorders.
Increasing Occurrence of Neurological Disorders
An opportunistic factor propelling the expansion of the worldwide neurointerventional device market is the rising incidence of neurological disorders and the expanding need for minimally invasive therapeutic alternatives. The increasing prevalence of vascular malformations, strokes, and aneurysms has increased the demand for sophisticated neurointerventional techniques. The increasing recognition of these disorders among healthcare practitioners and the general populace has led to a commensurate rise in the need for treatment modalities that are both efficacious and minimally invasive. Neurointerventional devices are of utmost importance in meeting this need as they provide novel approaches that mitigate patient distress, shorten recuperation periods, and improve overall treatment results.
The opportunistic expansion of the neurointerventional device market is further facilitated by the aging of the global population. There is a noticeable rise in the incidence of neurological disorders as individuals progress in age, resulting in an elevated need for interventions that can alleviate the consequences of these conditions. Due to the increased susceptibility of the elderly to conditions such as aneurysms and strokes, neuro interventional procedures are becoming more significant. As a result of technological advancements that make minimally invasive procedures safer and more effective, the elderly are increasingly likely to choose these procedures, which contributes to the market's growth.
An opportunity presents itself in the form of developing and distributing neurointerventional devices tailored to the specific requirements of geriatric patients. This would result in an enhanced quality of life for these patients and facilitate the long-term expansion of the market. In summary, the escalating incidence of neurological disorders and the expanding need for minimally invasive procedures, particularly among the elderly demographic, constitute a substantial advantageous factor for the worldwide neurointerventional device market.
The global market for neurointerventional devices is anticipated to experience significant expansion due to a confluence of factors including technological progress, rising incidence of neurological disorders, and changing healthcare environments across the globe. An essential factor driving market expansion is the perpetual development of neurointerventional devices. Prominent manufacturers are allocating substantial resources towards research and development endeavours to unveil innovative device designs and enhanced imaging modalities, which serve to augment the accuracy and effectiveness of neuro-interventional procedures. This advancement not only supports the enhancement of diagnostic precision but also contributes to the proliferation of minimally invasive therapeutic alternatives, thereby mitigating patient recuperation periods and post-procedural complications. The interplay between manufacturers and consumers significantly influences the dynamics of the market.
As healthcare professionals and patients become more cognizant of the advantages associated with neurointerventional procedures, the demand for such devices increases. To increase the adoption of their products, manufacturers are concentrating on establishing solid alliances with healthcare providers, providing extensive training programs, and guaranteeing the accessibility of technical support. Additionally, partnerships between healthcare institutions and manufacturers contribute to the adaptation of neurointerventional devices to meet the particular requirements of diverse patient populations. An increase in healthcare expenditure, a surge in the elderly population vulnerable to neurological disorders, and favourable reimbursement policies in developed economies are additional factors driving the market's expansion. Additionally, the incidence of conditions necessitating neurointerventional treatments is on the rise due to the increased prevalence of risk factors such as hypertension and diabetes.
The global market for neurointerventional devices is dominated by Medtronic, Stryker Corporation, Johnson & Johnson, Terumo Corporation, and Penumbra Inc. The substantial market share of these industry titans can be attributed to their comprehensive product portfolios, formidable research and development capacities, and astute acquisition strategies. The United States is a leading adopter of neurointerventional devices due to its advanced healthcare infrastructure and a significant incidence of neurological disorders.
Additionally, European nations, including Germany, and the UK, make substantial contributions, propelled by their highly developed healthcare systems. With a population that is aging at an accelerated rate, Japan is a significant market in Asia where neurointerventional procedures are in high demand.
Prominent entities in the neurointerventional device industry are exerting significant influence on the terrain using ongoing innovation and strategic alliances. Prominent organizations such as Medtronic and Stryker Corporation are making substantial investments in research and development to introduce cutting-edge technologies that will improve the accuracy and efficacy of neuro-interventional procedures.
Portfolios are strengthened through strategic acquisitions, such as Johnson & Johnson's purchase of Codman Neuro from DePuy Synthes. These entities are additionally emphasizing augmenting their worldwide footprint, specifically in developing economies of Asia-Pacific, to take advantage of the growing need for neurointerventional therapies. In addition to spearheading innovation, the market's dominant participants actively shape the competitive dynamics by implementing strategic initiatives and pursuing a global expansion strategy.
Which Product is Expected to be the Primary Focus Area?
Rising Global Stroke Cases Uphold Dominance of Neurovascular Thrombectomy
It is anticipated that the neurovascular thrombectomy sector will hold the most significant portion of the neurointerventional device market. The principal reasons for this are the escalating incidence of stroke cases worldwide and the expanding utilization of thrombectomy procedures as the conventional therapy for acute ischemic stroke. The growth of this segment is anticipated to be propelled by the increasing demand for devices that are specifically engineered for thrombectomy procedures, as neurointerventional techniques continue to advance.
It is projected that the flow diverters device segment will experience the most rapid growth among all neurointerventional device segments. The observed expansion can be ascribed to the increasing prevalence of intracranial aneurysms and the efficacy of flow diverters in managing these intricate ailments. With their novel approaches to redirecting blood flow away from aneurysms, these devices are anticipated to experience greater acceptability, thereby propelling the market's exponential expansion. Ongoing progressions in flow diverter technology and the broadening scope of their applications serve to augment the anticipated rapid expansion of this market segment.
Which of the Techniques Holds the Largest Market Share?
Cerebral Angiography Leads in Line with Widespread Integration in Various Treatments
It is anticipated that the cerebral angiography sector will hold the most significant portion of the neurointerventional device market. Cerebral angiography is an indispensable diagnostic procedure that aids in the diagnosis and planning of treatment for a wide range of neurological conditions by providing detailed images of blood vessels in the brain. Its extensive application in the evaluation and visualization of vascular abnormalities substantially contributes to the segment's predominance. It is projected that the neurothrombectomy procedure segment will experience the most rapid growth among all neurointerventional device segments.
The expansion is driven by the rising incidence of acute ischemic stroke cases and the expanding utilization of neurothrombectomy procedures as the prevailing therapeutic approach. With the growing need for efficient and minimally invasive methods to extract blood clots from cerebral arteries, the neurothrombectomy procedure sector is positioned for substantial growth. This is primarily due to ongoing technological advancements and a heightened recognition of the advantages it offers in terms of enhancing patient outcomes.
Which is the Prominent End User Category?
Hospitals Continue to be the Frontrunners, ASCs Accelerate Adoption
It is anticipated that hospitals will hold the most significant portion of the neurointerventional device market. Due to the wide array of neuro interventional procedures that frequently necessitate sophisticated infrastructure and specialized equipment, medical facilities are the predominant locations where these interventions take place. In addition, hospitals are the preferred care facilities for complex neuro-interventional procedures due to their comprehensive patient care services.
It is anticipated that the segment comprising ambulatory surgical centers (ASCs) will experience the most rapid growth among neurointerventional devices. The expansion can be ascribed to the rising inclination towards ambulatory care, which is propelled by various factors including economic viability, reduced recuperation periods, and technological progress enabling the implementation of less invasive procedures in advanced surgical centers. The rapid expansion of the neurointerventional center market is anticipated to be aided by the convenience and efficacy that ambulatory surgical centers provide as these techniques continue to advance.
North America Holds the Lion’s Share, Driven by the Highest Prevalence and Detection of Neurological Conditions
It is expected that North America will hold the largest market share in the worldwide neurointerventional device industry. The region's notable prevalence of neurological disorders, well-established healthcare infrastructure, and high adoption of advanced medical technologies are the primary factors contributing to this. In addition to favorable reimbursement policies and the presence of key market participants, robust research and development activities also contribute to North America's dominance. For instance, a geriatric population and greater awareness of neuro interventional procedures in the US both contribute to an increase in demand for these devices. Furthermore, the region's dominant market position is solidified through the enhancement of accessibility and utilization of neurointerventional devices through strategic collaborations between healthcare providers and manufacturers in North America.
Asia Pacific to Benefit from a Growing Effort Towards Improving Healthcare Access and Affordability
The region of South Asia, and the Pacific is anticipated to witness the most rapid expansion of the worldwide neurointerventional device market. A rising prevalence of neurological disorders, improved healthcare infrastructure, and increased investments in medical research and development are all contributing factors to this rapid expansion. The increasing healthcare consciousness and the expansion of the key nations such as India, and China are factors propelling the demand for sophisticated medical interventions, such as neuro-interventional procedures.
Moreover, the expansion of the market is facilitated by governmental initiatives that seek to improve the accessibility and affordability of healthcare. The rapid expansion of the region is further propelled by the entrance of international neurointerventional device manufacturers into these emerging markets and the evolving regulatory landscape. The ongoing progress of healthcare systems in South Asia, and the Pacific is anticipated to generate substantial demand for neurointerventional devices, thereby serving as a pivotal catalyst for the expansion of the global market.
Prominent entities in the neuro interventional device industry, including Medtronic, Stryker Corporation, Johnson & Johnson, Terumo Corporation, and Penumbra Inc., attain and sustain their maximum market share through the implementation of strategic initiatives. An essential element is their unwavering dedication to research and development (R&D) endeavours. These organizations allocate substantial resources toward the development of novel technologies and the enhancement of current products to maintain a leading position in the field of neuro-interventional procedures. For example, Medtronic consistently introduces state-of-the-art neurovascular devices, such as stents and embolic protection devices, thereby augmenting its market presence via the implementation of innovative strategies.
To broaden their product lines and enter new markets, these companies rely heavily on strategic partnerships and acquisitions. An exemplary instance is the acquisition of Codman Neuro by Johnson & Johnson from DePuy Synthes, which empowered the company to provide an extensive selection of neurointerventional devices. The acquisition of the Neurovascular Division from Covidien by Stryker Corporation further fortified the company's market position. By implementing such strategic manoeuvres, market leaders can provide a wide range of solutions, thereby increasing their market share in the neurointerventional device industry. An additional pivotal element that contributes to their market dominance is their global expansion. These businesses strategically focus on areas that have a significant incidence of neurological disorders and an increasing need for neurointerventional procedures.
2023 to 2030
Historical Data Available for
2018 to 2022
US$ Million for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon request
Embolic Protection Device
Flow Diverters Device
By End User:
Ambulatory Surgical Centers
South Asia & Oceania
Middle East & Africa
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
Danaher Corporation (Cepheid)
F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
Laboratory Corporation of America Holdings
Thermo Fisher Scientific, Inc.
The market is anticipated to grow at a CAGR of 4.7%% during the projected period.
The neurointerventional device market was valued at US$26 billion in 2023.
The US held the largest market share in 2023.
Some of the prominent players in the market are Abbott Laboratories, Becton, Dickinson and Company (Bd), Bio-Rad Laboratories, Inc., and Danaher Corporation (Cepheid).
The ASCS segment is expected to grow at the fastest CAGR during the forecast period.